Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Just in time: mal-HLH in Sweden, 1997 to 2018

Beth A. Martin

Blood (2024) 143 (3): 187–188.

https://doi.org/10.1182/blood.2023022062

Published: 2024

Journal Articles

Plasma Exchange for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy: Implications for Clinical Care and Clinical Trial Design

Vinay K. Giri, Muharrem Yunce, Srikanth Muppidi, Kavitha J. Ramchandran, Tamiko R. Katsumoto, Beth A Martin-Kool

Blood (2022) 140 (Supplement 1): 2835–2836.

https://doi.org/10.1182/blood-2022-171037

Published: 2022

Journal Articles

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Yazan Migdady, MD MSc, Ridhi Gupta, MBBS, Asiri Ediriwickrema, MD, Francisco Socola, MD, Sally Arai, MD, Beth A Martin, MD

Blood (2018) 132 (Supplement 1): 4976.

https://doi.org/10.1182/blood-2018-99-116560

Published: 2018

Journal Articles

Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital

Eric Lau, DO, Cynthia Gong, Pharm.D, Haley Weiner, Michael R. Jeng, MD, Natasha Purington, MS, Beth A Martin, MD

Blood (2017) 130 (Supplement 1): 3363.

https://doi.org/10.1182/blood.V130.Suppl_1.3363.3363

Published: 2017

Journal Articles

Transfusion Dependence Is Common in Adults with Hemophagocytic Lymphohistiocytosis (HLH) and Is Associated with EBV Viremia

Yazan Migdady, MDMSc, Haley Weiner, Eric Lau, DO, Beth A Martin, MD, Michael R. Jeng, MD, Jean Oak, MD

Blood (2017) 130 (Supplement 1): 3737.

https://doi.org/10.1182/blood.V130.Suppl_1.3737.3737

Published: 2017

NARROW

Just in time: mal-HLH in Sweden, 1997 to 2018

Plasma Exchange for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy: Implications for Clinical Care and Clinical Trial Design

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital

Transfusion Dependence Is Common in Adults with Hemophagocytic Lymphohistiocytosis (HLH) and Is Associated with EBV Viremia

Email alerts

ASH Publications

American Society of Hematology

Just in time: mal-HLH in Sweden, 1997 to 2018

Plasma Exchange for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy: Implications for Clinical Care and Clinical Trial Design

A Case Report of Refractory Immune Thrombocytopenia (ITP) Following Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) Successfully Treated with Off-Label Use of Daratumumab

Resource Utilization Associated with the Management of Adults with Hemophagocytic Lymphohistiocytosis (HLH): A Benchmark Analysis for Improving Inpatient Care at a Quaternary Hospital

Transfusion Dependence Is Common in Adults with Hemophagocytic Lymphohistiocytosis (HLH) and Is Associated with EBV Viremia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only